Clinical Features and Survival Outcomes of Unclassified High-Grade Neuroendocrine Carcinoma of the Lung Akciğerin Sınıflandırılamayan Yüksek Dereceli Nöroendokrin Karsinomaların Klinik Özellikleri ve Sağ Kalım Sonuçları


Söyler Y., AKIN KABALAK P., Kavurgacı S., DEMİRAĞ F., Yılmaz Ü.

Sakarya Medical Journal, cilt.13, sa.2, ss.295-304, 2023 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.31832/smj.1277259
  • Dergi Adı: Sakarya Medical Journal
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.295-304
  • Anahtar Kelimeler: high-grade neuroendocrine carcinoma, pulmonary neuroendocrine carcinomas, small-cell lung cancer
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Introduction Differentiating high-grade neuroendocrine carcinomas (HGNEC) is difficult. We aimed to assess the clinical features and survival outcomes of unclassified HGNEC (uHGNEC) and to compare it with small-cell lung cancer (SCLC). Materials and Methods This was a retrospective and observational study of HGNEC patients. Kaplan-Meier method was used to estimate progression-free survival (PFS) and overall survival (OS). Cox-regression analyses were used to determine the risk factors independently associated with PFS and OS. Results One hundred twenty-one patients [uHGNEC (n = 35), SCLC (n = 86)] were analysed. The primary tumour was mostly right-sided, located in the centre of the lungs. The IASLC stage at diagnosis was locally advanced in 43 (35.5%) patients and advanced in 78 (64.5%) patients. uHGNEC and SCLC groups shared similar clinical features. The study population's median PFS and OS were 8.8 (95%Cl 7.29 – 10.30) and 10.9 (95%Cl 9.9 – 11.8) months, respectively. uHGNEC-and SCLC groups had a similar PFS (9.4 vs 8.6 months, p = 0.99) and OS (12 vs 10.7 months, p = 0.51). The six-month, one-and two-year PFS and OS of the two groups were also similar. Among all patients, a right-sided tumour (HR: 1.558, 95%Cl 1.044 – 2.325, p = 0.03) and advanced-stage disease (HR: 1.928, 95%Cl 1.292 – 2.877, p = 0.001) were prognostic factors for poor OS. Cox-regression analysis indicated that histopathology did not have an impact on PFS and OS. Conclusion HGNEC patients who cannot be classified pathologically behave like SCLC.